JPRN-UMIN000026442已完成未知
Effects of concomitant administration of DPP-4 and SGLT2 inhibitors in Japanese patients with type 2 diabetes - Effects of concomitant administration of DPP-4 and SGLT2 inhibitors in Japanese patients with type 2 diabetes
agoya University0 个研究点目标入组 220 人开始时间: 2017年3月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 220
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Having severe nephropathy.
研究者
相似试验
已完成
不适用
The effects of the combination therapy of DPP-4 inhibitor alogliptin and alfa-glucosidase inhibitor on markers of inflammation and oxidative stress - comparison between Acarbose and Voglibosetype 2 diabetes mellitusJPRN-UMIN000007714Department of Internal Medicine, School of Medicine, Keio University40
已完成
不适用
Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control in type2 diabetes with dyslipidemiaType 2 diabetes mellitusJPRN-UMIN000010397Yokohama City University Medical Center150
招募中
不适用
Comparison of effects of a DPP-4 inhibitor and an alpha-glucosidase inhibitor on visceral fat and oxidative stress in type 2 diabetes mellitustype 2 diabetes mellitusJPRN-UMIN000011864Tokyo Women's Medical University100
进行中（未招募）
不适用
valuation of the effect of a new drug for diabetes on atherosclerosis in patients with primary failure metformiType 2 diabetesMedDRA version: 14.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2012-000152-34-ITAZIENDA UNIVERSITARIA POLICLINICO UMBERTO I DI ROMA64
已完成
不适用
Efficacy and safety of DPP-4 inhibitor added to insulin for treatment of type 2 diabetesType 2 diabetesJPRN-UMIN000004678Keio University , School of Mecidicine, Department of Internal Medicine50